Avantium N.V. (AVTX) AI Stock Analysis

• Market Cap: €125.80M
• Dividend Yield: N/A
• Average Volume (3M): 96.33K
• Price to Earnings (P/E): ―
• Beta (1Y): 1.22
• Revenue Growth: 6.78%
• EPS Growth: 42.01%
• Country: NL
• Employees: 284
• Sector: Technology
• Sector Strength: 92
• Industry: Chemicals - Specialty
• EPS (TTM): -2.01
• Shares Outstanding: 8,802,388
• 10 Day Avg. Volume: 62,004
• 30 Day Avg. Volume: 96,327
• PEG Ratio: N/A
• Price to Book (P/B): 11.31
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -0.97
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: €10.00
• Price Target Upside: -33.42% Downside
• Rating Consensus: Moderate Sell
• Number of Analyst Covering: 1

• Rating: 45 Neutral
• Price Target: €14.00 ▼(-6.79%Downside)

The overall stock score for Avantium N.V. is significantly impacted by poor financial performance, with major challenges in profitability and cash flow management. Technical analysis provides mixed signals, with no strong indicators of bullish momentum. Valuation is negatively affected by ongoing losses, as reflected in the negative P/E ratio and lack of dividend yield. The absence of earnings call data and corporate events further limits positive influences on the score.

Avantium N.V. Business Overview & Revenue Model

Company Description

Avantium N.V. (AVTX) is a Dutch technology company specializing in the development and commercialization of innovative chemical technologies. The company operates primarily in the renewable chemistry sector, focusing on creating sustainable solutions to replace fossil-based chemicals and materials. Avantium's core products and services include the development of plant-based polymers and chemicals, as well as licensing proprietary technologies for advanced chemical processes.

How the Company Makes Money

Avantium makes money through a combination of technology licensing, product sales, and strategic partnerships. The company's revenue model is centered around licensing its proprietary renewable chemistry technologies to industrial partners, enabling them to produce sustainable chemicals and materials. Additionally, Avantium generates income from the sale of its own plant-based products, such as bioplastics and biofuels. Strategic partnerships with chemical companies and research institutions also contribute to its earnings by facilitating joint development projects and expanding market access for its innovations.

Avantium N.V. Financial Statement Overview

Summary

Avantium N.V. demonstrates revenue growth but struggles with profitability and cash flow management. The balance sheet reflects high leverage and decreasing equity ratios, posing financial stability concerns. The company faces challenges in achieving operational efficiency and managing cash flows effectively, which are critical for improving financial health.

Income Statement

Avantium N.V. shows consistent revenue growth with a 6.8% increase from 2023 to 2024. However, the company faces significant profitability challenges, with negative gross profit margins and net profit margins over the years. The EBIT and EBITDA margins are also negative, indicating operational inefficiencies and high costs relative to revenue.

Balance Sheet

The company's balance sheet shows a high debt-to-equity ratio of 1.56 in 2024, indicating a leveraged position. The equity ratio has decreased to 33.2%, reflecting increased liabilities. Despite these challenges, the company maintains a stable asset base.

Cash Flow

Cash flow analysis reveals negative free cash flow trends, with a decrease of 4.8% from 2023 to 2024. The operating cash flow to net income ratio is negative, reflecting cash flow challenges. Additionally, the company's reliance on financing for liquidity is evident with substantial financing cash inflows.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	21.04M	19.70M	17.83M	10.92M	9.86M
Gross Profit	16.37M	-25.30M	14.06M	7.88M	7.52M
EBITDA	-24.52M	-26.61M	-19.59M	-16.09M	-14.91M
Net Income	-26.87M	-31.40M	-32.86M	-24.77M	-23.15M
Balance Sheet
Total Assets	288.63M	228.49M	162.03M	77.67M	69.98M
Cash, Cash Equivalents and Short-Term Investments	23.90M	35.22M	58.37M	33.41M	25.13M
Total Debt	149.18M	122.43M	24.80M	10.70M	9.71M
Total Liabilities	190.84M	174.62M	70.86M	27.65M	23.75M
Stockholders Equity	95.85M	46.17M	81.13M	50.03M	46.24M
Cash Flow
Free Cash Flow	-103.39M	-108.59M	-44.80M	-16.54M	-16.84M
Operating Cash Flow	-45.06M	-18.82M	-1.40M	-12.61M	-13.38M
Investing Cash Flow	-58.63M	-89.77M	-23.40M	-3.93M	-3.45M
Financing Cash Flow	92.42M	78.94M	54.76M	24.83M	-1.98M

Avantium N.V. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 15.02
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NL:AVTX, the sentiment is Negative. The current price of 15.02 is above the 20-day moving average (MA) of 14.77, above the 50-day MA of 14.30, and below the 200-day MA of 16.40, indicating a neutral trend. The MACD of 0.34 indicates Positive momentum. The RSI at 48.48 is Neutral, neither overbought nor oversold. The STOCH value of 29.29 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for NL:AVTX.

Avantium N.V. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ADYEN	72 Outperform	$49.13B	52.43	25.46%	―	17.05%	32.05%
TOM2	67 Neutral	€622.83M	―	-23.52%	―	-1.63%	-18.80%
THEON	60 Neutral	€1.97B	27.27		1.98%	―	―
Sector *	59 Neutral	€37.07B	6.95	-21.90%	2.10%	5.85%	57.81%
MTRK	51 Neutral	€191.29M	―		―	-7.94%	7.94%
AVTX	45 Neutral	€125.80M	―	-37.84%	―	6.78%	42.01%
CMCOM	44 Neutral	€180.35M	―	-57.80%	―	0.36%	34.49%